Ruxolitinib Remains Backbone in Myelofibrosis and MPN Treatment
An expert from Mount Sinai Hospital comments on potential new ruxolitinib combinations to treat patients with myelofibrosis and MPNs.
IASLC Releases Language Guide to Promote Stigma-Free Discourse
Patient advocate Jill Feldman led the development of the language guide to help promote patient-centered, stigma-free language across the lung cancer community.
Self-Awareness Is Critical in Treating Prescribing Patients With Cancer and Substance Abuse Disorders
Kathy Burns, MS, APRN-CNS, AGCNS-BC, of the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, comments on the importance of self-awareness as an oncology nurse when working to overcome one’s implicit bias.
More Research Is Needed in Cisplatin-Induced Hearing Loss in Pediatric Patients With Cancer
Bruce Carleton, PharmD, FCP, FISPE, discusses the implications of research findings indicating that very young children are at a higher risk of cisplatin-induced hearing loss.
Biomarker Screening Is Beneficial in Soft Tissue Sarcoma Clinical Trials
An expert discusses the value of enrolling patients with soft tissue sarcoma in histologically specific clinical trials.
Personal Bonds Make NP Fellowship Programs Advantageous Choice For Recent Graduates
Jessica MacIntyre, APRN, NP-C, AOCNP, explains how Hematology/Oncology Nurse Practitioner Fellowship at Sylvester Comprehensive Cancer Center prepares fellows for success.
Helping Patients Manage Cancer-Related Fatigue
Andrew Kass, MSN, RN, AGNP-C, AOCNP, discusses the impact fatigue can have on patients with cancer and how oncology nurses and APPs can help their patients address this common adverse event.
Advanced Practice Providers May Hold the Key to Improving Community Clinical Trial Involvement
Seventy-three percent of advanced practice providers reported that they are interested in becoming more involved with clinical trials.
The Value of a Fellowship Program in Redirecting One Nurse’s Career Goals
“Each step along the way has really helped me grow professionally, not just as a clinician, but as a whole practitioner, to make my transition to practice a lot easier and make me more comfortable… it’s really an invaluable experience.”
Prescribing Considerations for Patients with Chronic Leukemia
Stephanie Jackson, DNP, MSN, RN, AOCNS, BMTCN, Oncology Nursing News co-editor in chief, discusses the importance of NCCN guidelines in prescribing medications for patients with chronic leukemia. .
Sylvester Comprehensive Cancer Center’s NP Fellowship Successfully Retains 100% of Fellows
Jessica MacIntyre, executive director of clinical operations at Sylvester Comprehensive Cancer Center, explains how the small market for experienced oncology nurse practitioners prompted their institution to design a successful Hematology/Oncology Nurse Practitioner Fellowship.
Addressing Implicit Bias in Oncology Nursing
“It is not a ‘one and done kind of thing.” It is very important to implement these skills throughout the community. It's a practice. It's a behavioral change.”
Oncology Nurse Practitioner Fellowship Gears Itself Towards Recent Graduates
The Hematology/Oncology Nurse Practitioner Fellowship is a yearlong program which seeks to train those who have recently received their NP certification.
Advanced Practice Fellowships Prepare Recent Graduates for Success in Oncology
The Oncology Nurse Practitioner Fellowship at Sylvester Comprehensive Cancer Center exposes fellows to the gamut of oncology care and teaches the skills they need to succeed.
Prescribing Chemotherapy as an NP: Factors to Remember
Nurse practitioners play a key role in prescribing cancer drugs and educating patients about their therapies.
Get In-Tune With Patients: Music Can Help Alleviate Stress
Music can help alleviate stress and bring something familiar into an unfamiliar medical procedure.
A Step-by-Step Guide for Nurses Facing a Public Health Disaster
Oncology advanced practice registered nurses are key players in the mitigation, preparation, response, and recovery of a public health disaster, such as the COVID-19 pandemic.
NP Fellowship Helps Prepare Providers for Oncology Career
Nurse practitioners are more valuable than ever in the world of cancer care.
Onboarding Reference Guide Aids APPs Treating Patients Receiving Bone Marrow Transplant
The “cheat sheet” assisted advanced practice providers using a step-by-step guide that is updated frequently to allow for the most up-to-date information.
Certified Nurse Specialists’ Role in Achieving DSC Certifications
Certified nurse specialists play a crucial role in their institutions achieving Disease-Specific Care certifications – which can ultimately improve patient outcomes.
Lifestyle Medicine Clinic May Help Cancer Survivors Improve Their Diet, Physical Activity
A clinic for patients with a history of cancer led by an advanced practice nurse and a dietician may empower patients to improve their lifestyles through diet and exercise, especially since it may have an impact on their outcomes and future risk for diseases.
Nurse Practitioners Speak Out Against 'Outdated' Practice Models
Oncology nurse practitioners are both competent and compassionate, and undergo rigorous academic and clinical training to earn the NP next to their name. However, many states still require them to work under the supervision of a physician.
NP Explains Durvalumab' Benefit in NSCLC
Durvalumab showed a promising survival boost in stage III non-small cell lung cancer, and the immunotherapy agent was not as toxic as some thought it would be.
NP Offers Insights on CRC Updates, Treatment Options
A nurse practitioner discusses mutations, cancer sidedness, and treatment duration for patients with colorectal cancer.
Opioid Overview: Know What to Use and When
Pain management is both an art and a science, according to Jeannine Brant, PhD, APRN, AOCN, FAAN
3-Drug Carfilzomib Regimen Not Superior Than Standard of Care in Myeloma
Carfilzomib, lenalidomide, and dexamethasone did not demonstrate superior progression-free survival in newly diagnosed multiple myeloma.
Neoadjuvant Pembrolizumab Improves pCR Across ER+ Breast Cancer Subgroups
Tucatinib Continues to Show Benefit in Pretreated HER2+ Breast Cancer With Brain Metastases
Ribociclib Plus Endocrine Therapy Continues to Perform Well Across MONALEESA-2, -3, and -7 Trials
Patient-Reported Outcomes From CAPItello-291 Trial Support Capivasertib/Fulvestrant in HR+, HER2- Advanced Breast Cancer
2 Clarke Drive Cranbury, NJ 08512